BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3810100)

  • 1. [Roxithromycin (RU 28965), a new macrolide effective against pulmonary infections].
    Lachat JM; Anex JF; Regamey C
    Schweiz Med Wochenschr; 1986 Dec; 116(49):1739-41. PubMed ID: 3810100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute bronchopulmonary infections: treatment with i.v. spiramycin.
    Vachon F; Kernbaum S
    Chemioterapia; 1987 Aug; 6(4):282-5. PubMed ID: 3308147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO; Ohaju-Obodo J
    West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Roxithromycin in the treatment of community-acquired pneumonia].
    Antela A; Guerrero A; Montilla P; Hermida JM; Fortún J; Pérez Elías MJ; Quereda C; Navas E
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):260-2. PubMed ID: 8324023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects of macrolides: contribution of roxithromycin].
    Bertrand A; Jonquet O
    Rev Med Interne; 1987; 8(5):527-32. PubMed ID: 3328252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumonia in clinical practice: diagnosis and therapy].
    Zimmerli W
    Praxis (Bern 1994); 1994 Dec; 83(49):1374-7. PubMed ID: 7801011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
    Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Young RA; Gonzalez JP; Sorkin EM
    Drugs; 1989 Jan; 37(1):8-41. PubMed ID: 2651088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical pneumonia syndrome.
    File TM; Tan JS; Murphy DP
    Prim Care; 1981 Dec; 8(4):673-94. PubMed ID: 6915590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
    Bertinieri G; Caser L; Ceffa G; Cortese P; Martina C; Riccardi G; Calogero G
    Minerva Med; 1987 Nov; 78(21):1625-7. PubMed ID: 3500430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses.
    Hannan PC; Bhogal BS; Fish JP
    Res Vet Sci; 1982 Jul; 33(1):76-88. PubMed ID: 7134653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Community-acquired pneumonia].
    Mayer KH; Hochreiter K
    Acta Med Austriaca; 1993; 20(5):124-6. PubMed ID: 8128827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview.
    Gentry LO
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():145-52. PubMed ID: 3323166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Community-acquired pneumonias: importance of pneumococcal pathology].
    Glauser MP; Bille J
    Schweiz Med Wochenschr; 1985 Jan; 115(3):70-5. PubMed ID: 3871965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is new in the treatment of community-acquired pneumonia?].
    Welte T; Marre R; Suttorp N;
    Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroaerosol antibiotics in the treatment of viral-bacterial pneumonia].
    Zlydnikov DM
    Ter Arkh; 1974; 46(5):119-22. PubMed ID: 4428382
    [No Abstract]   [Full Text] [Related]  

  • 17. [Roxithromycin--a new macrolide antibiotic in the treatment of respiratory diseases and campylobacteriosis].
    Havlík J; Koudelka V; Hájková D
    Cesk Pediatr; 1988 Sep; 43(9):535-7. PubMed ID: 3197156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effect of midecamycin on Mycoplasma pneumoniae pneumonia in adults (author's transl)].
    Kikuchi N; Kobayashi A; Kanno H; Ishihara K; Kato S; Kiuchi N; Iwama S; Mori Y
    Jpn J Antibiot; 1979 Apr; 32(4):555-61. PubMed ID: 459086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and treatment of viral, viral-bacterial and bacterial pneumonias during influenza epidemic, 1974-75].
    Rabukhin AE; Egorova LI; Sergeiuk EM; Rozhkova VV; Perelygina GA
    Ter Arkh; 1976; 48(12):13-21. PubMed ID: 1013889
    [No Abstract]   [Full Text] [Related]  

  • 20. [Double-blind comparative study of roxithromycin (RU 28965) and midecamycin acetate (MOM) in the treatment of pneumonia].
    Soejima R; Niki Y; Hino J; Kishimoto T; Nakagawa Y; Sumi M; Saito A; Nakayama I; Tomizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1989 May; 63(5):501-29. PubMed ID: 2506305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.